好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Medical Reasons for Dose Adjustment and/or Discontinuation of Mitoxantrone in Clinical Practice
MS and Related Diseases
(-)
174
Authors/Disclosures
Annette Wundes, MD, FAAN (University of Washington) The institution of Dr. Wundes has received research support from Benaroya Research Institute .
George H. Kraft, MD (University of Washington) No disclosure on file
No disclosure on file
James D. Bowen, MD (Swedish Neuroscience Institute) Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyers Squibb. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bowen has received research support from Biogen IDEC. The institution of Dr. Bowen has received research support from Genentech. The institution of Dr. Bowen has received research support from Genzyme. The institution of Dr. Bowen has received research support from Novartis. The institution of Dr. Bowen has received research support from Roche.
No disclosure on file
No disclosure on file
No disclosure on file